356 related articles for article (PubMed ID: 33721334)
21. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy.
Viers BR; Sukov WR; Gettman MT; Rangel LJ; Bergstralh EJ; Frank I; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
Eur Urol; 2014 Dec; 66(6):1116-24. PubMed ID: 25052213
[TBL] [Abstract][Full Text] [Related]
22. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
[TBL] [Abstract][Full Text] [Related]
23. Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration.
Wood HM; Reuther AM; Gilligan TD; Kupelian PA; Modlin CS; Klein EA
J Urol; 2007 Oct; 178(4 Pt 1):1271-6. PubMed ID: 17698101
[TBL] [Abstract][Full Text] [Related]
24. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
25. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE
Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088
[TBL] [Abstract][Full Text] [Related]
27. SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy.
Faisal FA; Kaur HB; Tosoian JJ; Tomlins SA; Schaeffer EM; Lotan TL
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):552-559. PubMed ID: 30850708
[TBL] [Abstract][Full Text] [Related]
28. Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical Prostatectomy.
Weprin SA; Parker DC; Jones JD; Kaplan JR; Giusto LL; Mydlo JH; Yu SS; Lee DI; Eun DD; Reese AC
Clin Genitourin Cancer; 2019 Oct; 17(5):e1054-e1059. PubMed ID: 31303559
[TBL] [Abstract][Full Text] [Related]
29. Oncologic outcomes in prostate cancer patients treated with robot-assisted radical prostatectomy: results from a single institution series with more than 10 years follow up.
Bianchi L; Gandaglia G; Fossati N; Larcher A; Pultrone C; Turri F; Selli C; de Groote R; de Naeyer G; Borghesi M; Schiavina R; Brunocilla E; Briganti A; Montorsi F; Mottrie A
Minerva Urol Nefrol; 2019 Feb; 71(1):38-46. PubMed ID: 30547906
[TBL] [Abstract][Full Text] [Related]
30. Does Any Racial Disparity Exist in Oncologic Outcomes After Primary Cryotherapy for Prostate Cancer? A Matched-pair Comparative Analysis of the Cryo On-Line Data Registry.
Aminsharifi A; Polascik TJ; Tsivian M; Schulman A; Tsivian E; Tay KJ; Elshafei A; Jones JS
Clin Genitourin Cancer; 2018 Oct; 16(5):e1073-e1076. PubMed ID: 30054221
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic.
Bernstein AN; Talwar R; Handorf E; Syed K; Danella J; Ginzburg S; Belkoff L; Reese AC; Tomaszewski J; Trabulsi E; Singer EA; Jacobs B; Kutikov A; Uzzo R; Raman JD; Guzzo T; Smaldone MC; Correa A
JAMA Oncol; 2021 Oct; 7(10):1467-1473. PubMed ID: 34292311
[TBL] [Abstract][Full Text] [Related]
32. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
33. African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance.
Deka R; Parsons JK; Simpson DR; Riviere P; Nalawade V; Vitzthum LK; Kader AK; Kane CJ; Rock CS; Murphy JD; Rose BS
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):581-588. PubMed ID: 32327702
[TBL] [Abstract][Full Text] [Related]
34. Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases.
Wenger H; Weiner AB; Razmaria A; Paner GP; Eggener SE
Urol Oncol; 2017 Jan; 35(1):31.e1-31.e6. PubMed ID: 27692833
[TBL] [Abstract][Full Text] [Related]
35. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.
Amling CL; Riffenburgh RH; Sun L; Moul JW; Lance RS; Kusuda L; Sexton WJ; Soderdahl DW; Donahue TF; Foley JP; Chung AK; McLeod DG
J Clin Oncol; 2004 Feb; 22(3):439-45. PubMed ID: 14691120
[TBL] [Abstract][Full Text] [Related]
36. Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.
Bissonette EA; Fulmer BR; Petroni GR; Moul JW; Theodorescu D
J Urol; 2001 Oct; 166(4):1328-31; discussion 1331-2. PubMed ID: 11547067
[TBL] [Abstract][Full Text] [Related]
37. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and oncological outcomes in negative multiparametric MRI patients undergoing robot-assisted radical prostatectomy.
Wagaskar VG; Ratnani P; Levy M; Moody K; Garcia M; Pedraza AM; Parekh S; Pandav K; Shukla B; Sobotka S; Haines K; Wiklund P; Tewari A
Prostate; 2021 Aug; 81(11):772-777. PubMed ID: 34057211
[TBL] [Abstract][Full Text] [Related]
39. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.
Yamoah K; Deville C; Vapiwala N; Spangler E; Zeigler-Johnson CM; Malkowicz B; Lee DI; Kattan M; Dicker AP; Rebbeck TR
Urol Oncol; 2015 Feb; 33(2):70.e15-22. PubMed ID: 25304288
[TBL] [Abstract][Full Text] [Related]
40. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis.
Powell IJ; Dey J; Dudley A; Pontes JE; Cher ML; Sakr W; Grignon DJ; Wood DP
Urology; 2002 Jun; 59(6):907-12. PubMed ID: 12031379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
